LAMEA Digestive Enzyme Supplements Market Size, Share & Industry Trends Analysis Report By Application (Additional supplements, Medical & Infant Nutrition and Sports Nutrition), By Origin (Animal, Plant, Microbial), By Country and Growth Forecast, 2022 - 2028
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the LAMEA Digestive Enzyme Supplements Market
Market Report Description
The Latin America, Middle East and Africa Digestive Enzyme Supplements Market would witness market growth of 13.6% CAGR during the forecast period (2022-2028).
Some people lack the enzyme necessary to break down the sugars in beans. These patients might benefit from taking an alpha-galactosidase supplement like Beano or Bean Relief. Digestive enzyme supplements help stop uncomfortable symptoms including cramps in the abdomen, flatulence, bloating, and diarrhea because they guard against the malabsorption that can cause digestion to slow down.
People who lack the biological enzyme lactase, which aids in the digestion of lactose, the sugar in milk products, sometimes use over-the-counter (OTC) lactase supplements to prevent acid reflux when consuming dairy products. The digestive enzymes found in supplements come from a variety of sources, including plants and the pancreases of pigs, cows, and sheep. For instance, lactase is made from filtered yeasts or parasites, whereas papain and bromelain are created from papayas and pineapples, respectively.
The number of people with several digestive and GI disorders is very high in the region, especially in Sub-Saharan Africa. Due to the existence of numerous risk factors that aid in the transmission of diarrheal diseases, a considerable number of at-risk populations in sub-Saharan Africa (SSA) continue to be in risk of contracting these illnesses. Numerous studies have demonstrated that the burden of GI is still disproportionately high on the African continent, particularly in areas where poverty is prevalent. The prevalence of diarrheal disorders is linked to three Millennium Development Goals.
The Brazil market dominated the LAMEA Digestive Enzyme Supplements Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $33.6 Million by 2028.The Argentina market is experiencing a CAGR of 14.2% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 13.3% during (2022 - 2028).
Based on Application, the market is segmented into Additional supplements, Medical & Infant Nutrition and Sports Nutrition. Based on Origin, the market is segmented into Animal, Plant, Microbial and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ProThera, Inc., Enzymes, Inc., AST Enzymes, Vemo 99 Ltd., Zeus Biotech Pvt. Ltd., Metagenics, Inc., Xymogen, HVL, LLC, Ortho Molecular Products, Inc., and Enzymedica, Inc.
Scope of the Study
Market Segments Covered in the Report:
- Additional supplements
- Medical & Infant Nutrition
- Sports Nutrition
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- ProThera, Inc.
- Enzymes, Inc.
- AST Enzymes
- Vemo 99 Ltd.
- Zeus Biotech Pvt. Ltd.
- Metagenics, Inc.
- HVL, LLC
- Ortho Molecular Products, Inc.
- Enzymedica, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free